Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 39 clinical trials
Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3 (DOLCE)

Protocol Title: DOLCE: Dolutegravir-Lamivudine for naïve HIV-Infected Patients with ≤200 CD4/mm3 Protocol Number: FH-57 Study Objectives: To assess the antiviral activity at week

  • 0 views
  • 27 Jul, 2022
  • 8 locations
Changes in Weight Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals

Randomized controlled parallel open-label study in people living with HIV and at least 6 month of treatment with dolutegravir/abacavir/lamivudine prior to inclusion. Participants (n=95

lamivudine
abacavir
HIV Vaccine
dolutegravir
  • 0 views
  • 02 Jun, 2021
  • 5 locations
Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone (DOLUVOIR)

The main objective of the study is to characterize the diffusion of dolutegravir and associated backbone (abacavir/lamivudine or tenofovir/emtricitabine) in HIV-1 chronic patients in the main

  • 0 views
  • 22 Mar, 2022
  • 1 location
DORA: A Doravirine-based First-line Antiretroviral Therapy for Women of Reproductive Potential Living With HIV (DORA)

reproductive potential living with HIV-1 switched from Efavirenz or Dolutegravir-based antiretroviral therapy on metabolic and neuropsychiatric outcomes.

  • 0 views
  • 17 Jun, 2022
  • 1 location
INSTI's For The Management of HIV-associated TB (INSIGHT)

dolutegravir-containing ART regimens in patients with drug-susceptible TB through 48 weeks

  • 0 views
  • 17 Mar, 2022
DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women (PREGNANT)

The study aims to evaluate the safety and efficacy of a 2 drugs ART regimen (lamivudine plus dolutegravir) for prevention of mother to child transmission in pregnant women with HIV. 20 pregnant

lamivudine
dolutegravir
Accepts healthy volunteers
mother-to-child transmission
  • 0 views
  • 25 Mar, 2022
  • 1 location
Doravirine for Persons With Excessive Weight Gain on Integrase Inhibitors and Tenofovir Alafenamide

reduction in overall body weight at 48 weeks compared to persons continued on an INSTI + TAF/FTC (or TAF/3TC) combination. INSTINs assessed in A5391 include bictegravir (BIC), dolutegravir (DTG), or

hiv-1 rna measurement
integrase inhibitors
antibody test
raltegravir
immune globulin
  • 48 views
  • 15 Mar, 2022
  • 21 locations
Triumeq in Amyotrophic Lateral Sclerosis (LIGHTHOUSE II)

To determine if Triumeq improves survival in Amyotrophic Lateral Sclerosis (ALS) compared with placebo

  • 0 views
  • 30 May, 2022
  • 2 locations
PK of JULUCA in Hemodialysis

This study will compare the pharmacokinetics of the component drugs in JULUCA, and HIV combination treatment pill, in HIV-negative patients who require hemodialysis with those with normal renal function.

Accepts healthy volunteers
bilateral oophorectomy
dialysis
chronic hemodialysis
  • 0 views
  • 09 Dec, 2021
  • 1 location
Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection

Reducing HIV persistence in lymph nodes by Interleukin-15 (IL-15) Receptor super-agonist (N-803) in Individuals with Acute HIV Infection

  • 0 views
  • 18 Oct, 2021
  • 1 location